Literature DB >> 22411092

Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure.

Yukie Enomoto1, Keisuke Enomoto, Shinya Uchino, Hiroshi Shibuya, Shin Watanabe, Shiro Noguchi.   

Abstract

BACKGROUND: Cancer of the thyroid gland is rare in children and adolescents. A history of neck irradiation is a well-established risk factor for tumor development, and most previous reports focused on cases that were induced by radiation exposure. We present here a retrospective review of the clinical features, treatment, and long-term outcome of children and adolescents with papillary thyroid cancer (PTC) without a history of radiation exposure who were treated at our institution over a period of ~50 years.
METHODS: We retrospectively investigated 142 PTC patients without an irradiation history who were younger than 20 years of age when treated from 1961 to 2005 (17 males and 125 females; mean age = 16.3 ± 2.7 years; follow-up = 21.8 ± 12.0 years). The clinicopathological results were evaluated using the medical records. Disease-free survival (DFS) and cause-specific survival (CSS) were assessed with the Kaplan-Meier method and compared with the log-rank test. Parametric analyses were performed using Student's t test and nonparametric analyses were performed using the Mann-Whitney U test.
RESULTS: At diagnosis, three patients had distant lung metastasis and 33 had gross neck lymph node (LN) metastasis. All patients were treated with surgery (hemi/partial thyroidectomy in 45 patients, subtotal thyroidectomy in 85, total thyroidectomy in 12, no LN dissection in 50, central compartment dissection in 20, and modified radical neck dissection in 72), and postoperative external beam radiation therapy was administered to 59. Postoperative ablative therapy using I(131) was not performed in this series. Recurrence was found for regional LN (n = 25), lung (n = 9), remnant thyroid (n = 5), and others (n = 4). DFS and CSS at 40 years were 74.1 and 97.5%, respectively. DFS was significantly worse in patients aged <16 years with a family history of thyroid cancer, preoperative neck gross LN metastasis, maximum tumor diameter, and extrathyroidal invasion. Preoperative gross neck LN metastasis and distant metastasis at diagnosis were significant factors for CSS. No other factors contributed to DFS and CSS. When the clinical features of children and adolescents were compared, the incidence of preoperative gross neck LN metastasis and distant metastasis at diagnosis and tumors with a maximum diameter >10 mm were significantly higher in the children group than in the adolescent group. DFS was significantly shorter in the children group than in the adolescent group, but no significant difference was found in CSS between these two groups.
CONCLUSIONS: The prognosis of PTC in children and adolescents is excellent, regardless of the extent of thyroidectomy and LN dissection. We recommend that only children or adolescents with preoperative gross neck LN metastasis and distant metastasis at diagnosis should be subjected to postoperative ablative therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22411092     DOI: 10.1007/s00268-012-1558-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  35 in total

1.  Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.

Authors:  K D Newman; T Black; G Heller; R G Azizkhan; G W Holcomb; C Sklar; V Vlamis; G M Haase; M P La Quaglia
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

2.  Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics.

Authors:  M D Tronko; T I Bogdanova; I V Komissarenko; O V Epstein; V Oliynyk; A Kovalenko; I A Likhtarev; I Kairo; S B Peters; V A LiVolsi
Journal:  Cancer       Date:  1999-07-01       Impact factor: 6.860

3.  Recurrence and morbidity in differentiated thyroid carcinoma in children.

Authors:  M P La Quaglia; M T Corbally; G Heller; P R Exelby; M F Brennan
Journal:  Surgery       Date:  1988-12       Impact factor: 3.982

4.  Familial cancers in a nationwide family cancer database: age distribution and prevalence.

Authors:  K Hemminki; P Vaittinen
Journal:  Eur J Cancer       Date:  1999-07       Impact factor: 9.162

5.  Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.

Authors:  C A Welch Dinauer; R M Tuttle; D K Robie; D R McClellan; R L Svec; C Adair; G L Francis
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

6.  Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children.

Authors:  B Jarzab; D Handkiewicz Junak; J Włoch; B Kalemba; J Roskosz; A Kukulska; Z Puch
Journal:  Eur J Nucl Med       Date:  2000-07

7.  Familial papillary carcinoma of the thyroid.

Authors:  S S Stoffer; D L Van Dyke; J V Bach; W Szpunar; L Weiss
Journal:  Am J Med Genet       Date:  1986-12

8.  A population-based case-control study of thyroid cancer.

Authors:  E Ron; R A Kleinerman; J D Boice; V A LiVolsi; J T Flannery; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

9.  Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France.

Authors:  F Pacini; T Vorontsova; E P Demidchik; E Molinaro; L Agate; C Romei; E Shavrova; E D Cherstvoy; Y Ivashkevitch; E Kuchinskaya; M Schlumberger; G Ronga; M Filesi; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

10.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

View more
  19 in total

1.  Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.

Authors:  Jennifer L Marti; Kunal S Jain; Luc G T Morris
Journal:  Thyroid       Date:  2015-05-06       Impact factor: 6.568

2.  Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from belarus exposed to radioiodines after the Chernobyl accident.

Authors:  Lydia B Zablotska; Eldar A Nadyrov; Alexander V Rozhko; Zhihong Gong; Olga N Polyanskaya; Robert J McConnell; Patrick O'Kane; Alina V Brenner; Mark P Little; Evgenia Ostroumova; Andre Bouville; Vladimir Drozdovitch; Viktor Minenko; Yuri Demidchik; Alexander Nerovnya; Vassilina Yauseyenka; Irina Savasteeva; Sergey Nikonovich; Kiyohiko Mabuchi; Maureen Hatch
Journal:  Cancer       Date:  2014-10-28       Impact factor: 6.860

3.  Differentiated thyroid carcinoma: comparison of histopathologic characteristics, clinical course, and outcome between young children and adolescents.

Authors:  M Motazedian; B Shafiei; P Vatankhah; S Hoseinzadeh; M Mirzababaee; L Fathollahi; M Ansari; N Baharfar; F Tabeie; I Neshandar Asli
Journal:  Med Oncol       Date:  2013-02-20       Impact factor: 3.064

4.  Surgical management of papillary thyroid carcinoma in childhood and adolescence: an Italian multicenter study on 250 patients.

Authors:  C Spinelli; S Strambi; L Rossi; S Bakkar; M Massimino; A Ferrari; P Collini; G Cecchetto; G Bisogno; A Inserra; F Bianco; P Miccoli
Journal:  J Endocrinol Invest       Date:  2016-04-29       Impact factor: 4.256

Review 5.  Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Svante Jansson; Marcin Barczyński; Peter Goretzki
Journal:  Langenbecks Arch Surg       Date:  2013-11-22       Impact factor: 3.445

6.  Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence.

Authors:  Olga Karapanou; Marinella Tzanela; Phoebe Rondogianni; Catherine Dacou-Voutetakis; Dimitrios Chiotis; Barbara Vlassopoulou; Dimitra Vassiliadi; Christina Kanaka-Gantenbein; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2020-06-13       Impact factor: 3.633

7.  Communicating with residents about 10 years of scientific progress in understanding thyroid cancer risk in children after the Fukushima Dai-ichi Nuclear Power Station accident.

Authors:  Gen Suzuki
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

Review 8.  Radiation exposure and the risk of pediatric thyroid cancer.

Authors:  Megumi Miyakawa
Journal:  Clin Pediatr Endocrinol       Date:  2014-08-06

9.  Primary ectopic substernal thyroid cancer with trachea relapse: a case report and opinions of management.

Authors:  Rui-Min Ma; Lin Lv; Shu-Rong Zheng; Jie You; Du-ping Huang; Gui-Long Guo
Journal:  World J Surg Oncol       Date:  2016-03-31       Impact factor: 2.754

Review 10.  Inherited Thyroid Tumors With Oncocytic Change.

Authors:  Marcelo Correia; Ana Rita Lima; Rui Batista; Valdemar Máximo; Manuel Sobrinho-Simões
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-09       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.